KMID : 0032220200320060481
|
|
Annals of Dermatology 2020 Volume.32 No. 6 p.481 ~ p.486
|
|
Possible Role of Lysine Demethylase 2A in the Pathophysiology of Psoriasis
|
|
Kim Dong-Ha
Choi Mi-Ra Lee Jae-Kyung Hong Dong-Kyun Jung Kyung-Eun Choi Chong-Won Lee Young Kim Chang-Deok Seo Young-Joon Lee Jeung-Hoon
|
|
Abstract
|
|
|
Background: Psoriasis is a common chronic inflammatory skin disease. The development of psoriasis is dependent on many intercellular events such as innate immunity and T cell-mediated inflammation. Furthermore, genetic factors are strongly implicated in the pathophysiology of psoriasis. Although a variety of susceptible genes are identified, it is likely that many important genes remain undisclosed.
Objective: The aim of this study is to investigate the possible role of lysine demethylase 2A (KDM2A) in the pathophysiology of psoriasis.
Methods: We examined the expression of KDM2A using a well established imiquimod-induced psoriasiform dermatitis model.
Results: Immunohistochemistry analysis showed that expression of KDM2A was increased in imiquimod-induced psoriasiform dermatitis. Consistent with this result, KDM2A level was markedly increased in the epidermis of psoriatic patient. When keratinocytes were stimulated with TLR3 agonist poly(I:C), KDM2A was increased at both the mRNA and protein levels. Poly(I:C) increased the expression of psoriasis-related cytokines including tumor necrosis factor-¥á, interleukin-8, and CCL20, and KDM2A inhibitor daminozide enhanced the poly(I:C)-induced cytokine expression. Finally, topical co-application of imiquimod and daminozide exacerbated the imiquimod-induced psoriasiform dermatitis.
Conclusion: Together, these results suggest that KDM2A is increased to negatively regulate the inflammatory reaction of epidermal keratinocytes in psoriasis.
|
|
KEYWORD
|
|
Imiquimod, Keratinocytes, Lysine demethylase 2A, Polyinosinic: polycytidylic acid, Psoriasis
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|